PKO Investment Management Joint-Stock’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.87M | Buy |
18,800
+3,500
| +23% | +$1.84M | 1.06% | 23 |
|
|
2025
Q1 | $9.7M | Buy |
15,300
+4,500
| +42% | +$2.85M | 1.1% | 21 |
|
|
2024
Q4 | $7.69M | Buy |
10,800
+10,000
| +1,250% | +$7.12M | 0.96% | 18 |
|
|
2024
Q3 | $841K | Buy |
800
+500
| +167% | +$526K | 0.1% | 120 |
|
|
2024
Q2 | $315K | Hold |
300
| – | – | 0.04% | 159 |
|
|
2024
Q1 | $290K | Hold |
300
| – | – | 0.03% | 152 |
|
|
2023
Q4 | $263K | Hold |
300
| – | – | 0.03% | 139 |
|
|
2023
Q3 | $247K | Sell |
300
-800
| -73% | -$658K | 0.03% | 130 |
|
|
2023
Q2 | $790K | Buy |
1,100
+900
| +450% | +$647K | 0.1% | 115 |
|
|
2023
Q1 | $164K | Sell |
200
-400
| -67% | -$329K | 0.02% | 141 |
|
|
2022
Q4 | $433K | Hold |
600
| – | – | 0.06% | 122 |
|
|
2022
Q3 | $413K | Sell |
600
-600
| -50% | -$413K | 0.07% | 115 |
|
|
2022
Q2 | $709K | Hold |
1,200
| – | – | 0.1% | 102 |
|
|
2022
Q1 | $838K | Sell |
1,200
-1,092
| -48% | -$763K | 0.1% | 100 |
|
|
2021
Q4 | $1.45M | Buy |
2,292
+1,592
| +227% | +$1.01M | 0.16% | 88 |
|
|
2021
Q3 | $424K | Hold |
700
| – | – | 0.05% | 102 |
|
|
2021
Q2 | $391K | Hold |
700
| – | – | 0.05% | 92 |
|
|
2021
Q1 | $331K | Hold |
700
| – | – | 0.05% | 79 |
|
|
2020
Q4 | $338K | Hold |
700
| – | – | 0.06% | 72 |
|
|
2020
Q3 | $392K | Hold |
700
| – | – | 0.08% | 70 |
|
|
2020
Q2 | $437K | Hold |
700
| – | – | 0.1% | 68 |
|
|
2020
Q1 | $342K | Buy |
+700
| New | +$342K | 0.12% | 66 |
|